U.S. markets close in 2 hours 16 minutes
  • S&P 500

    3,900.14
    -1.68 (-0.04%)
     
  • Dow 30

    31,572.73
    +37.22 (+0.12%)
     
  • Nasdaq

    13,503.36
    -85.47 (-0.63%)
     
  • Russell 2000

    2,248.64
    -26.68 (-1.17%)
     
  • Crude Oil

    60.68
    +0.04 (+0.07%)
     
  • Gold

    1,737.20
    +14.20 (+0.82%)
     
  • Silver

    26.98
    +0.30 (+1.11%)
     
  • EUR/USD

    1.2090
    +0.0031 (+0.25%)
     
  • 10-Yr Bond

    1.4270
    -0.0190 (-1.31%)
     
  • GBP/USD

    1.3975
    +0.0054 (+0.39%)
     
  • USD/JPY

    106.7300
    0.0000 (0.00%)
     
  • BTC-USD

    47,782.77
    -1,201.86 (-2.45%)
     
  • CMC Crypto 200

    957.82
    -28.83 (-2.92%)
     
  • FTSE 100

    6,613.75
    +25.22 (+0.38%)
     
  • Nikkei 225

    29,408.17
    -255.33 (-0.86%)
     

Top Stock Picks for Week of February 1, 2021

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Panel Of Zacks Experts
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Hologic Inc. HOLX develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women.Hologic exited fiscal first quarter with better-than-expected earnings and in-line revenues. Rise in organic revenues amid the pandemic-led business disruptions is encouraging. Hologic has been making impressive progress in its Breast Health arm over the past few months. Growth in Diagnostic revenues, led by improvements in Molecular Diagnostics, buoys optimism. Robust demand for COVID-19-related products and ongoing recovery in other arms have enabled Hologic to provide a strong fiscal second-quarter outlook, which instills investors’ confidence. Recently announced buyouts and receipt of regulatory approvals bode well for Hologic. Expansion of both margins looks encouraging. Over the past six months, Hologic has outperformed its industry.

MarineMax, Inc. HZO is the nation's largest recreational boat and yacht retailer. In addition to being a Zacks Rank #1 (Strong Buy), MarineMax enjoys the rare combination of have a Zacks Value Style Score of A, Growth Style Score of A, Momentum Style Score of B, which helps it round out with a VGM Composite Score of A. The reason for the favorable Zacks Rank is the series of recent earnings estimate revisions to the upside. Over the last month alone, four analysts have increased their earnings estimates for next year while three have done so for the current year. It has pushed up our Zacks Consensus Estimate for the current year. Currently, the historical EPS growth rate for MarineMax is in double digits. But investors should also focus on the projected growth. The company's EPS is expected to grow solidly this year, versus the industry average. 

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Hologic, Inc. (HOLX) : Free Stock Analysis Report
 
MarineMax, Inc. (HZO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research